News Theracryf Plc

Equities

EVG

GB00BSVYN304

Delayed London S.E. Other stock markets 01:30:27 01/05/2024 pm IST			5-day change	1st Jan Change
0.8 ^GBX	+6.67%		0.00%	-50.00%

26/04	Evgen Pharma plc will Change its Ticker to TCF from EVG	CI
26/04	Evgen Pharma plc will Change its Name to TheraCryf plc	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evgen Pharma plc will Change its Ticker to TCF from EVG	26/04	CI
Evgen Pharma plc will Change its Name to TheraCryf plc	26/04	CI
Norcros sells Johnson Tiles UK; Trifast trading well	26/04	AN
Northcoders launches bootcamp; Schroder invests	04/04	AN
Evgen Pharma Concludes Retail Offer of Shares	04/04	MT
Evgen Pharma plc - Retail Offer	20/03	AQ
Evgen Pharma plc - Acquisition, Fundraising and Change of Name	20/03	AQ
Evgen Pharma Signs Takeover Deal with Chronos Therapeutics; Raises Capital Via Share Issue, Subscription	20/03	MT
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat	20/03	AN
Evgen Pharma plc agreed to acquire Chronos Therapeutics Ltd. from group of shareholders for £3.4 million.	19/03	CI
Evgen Pharma finds evidence of SFX-01 activity in colon cancer models	27/02	AN
Evgen Pharma plc Announces That the Laboratories of Professor Grace Chen, Associate Professor Justin Colacino, and Professor Duxin Sun At the University of Michigan, Usa Have Observed Activity of Sfx-01 in Models of Colon Cancer	27/02	CI
Evgen Pharma plc - Positive update on SFX-01 in vitro Glioblastoma studies	20/02	AQ
Evgen Pharma shares up on studies into SFX-01 product progressing well	19/02	AN
Evgen Pharma plc Announces That the Laboratory of Dr Marjolein Geurts, Neuro-Oncologist At the Erasmus University Medical Centre Has Observed Continuing Activity of Sfx-01 in Gbm Cells	19/02	CI
Apax opts against lifting offer; DCI enters loan deal	10/02	AN
FTSE 100 falls at end of tepid week	09/02	AN
Evgen Pharma Issues Notice of Dispute to Stalicla Over Missed Milestone Payment	09/02	MT
Evgen partner raises USD17.4 million to support pipeline	17/01	AN
Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA	16/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Theracryf Plc

Equities

EVG

GB00BSVYN304

Summary

Filters